Longboard Pharmaceuticals Income Statement

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2017 - 2021
Period Ending	Jun '25 Jun 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2017 - 2021
Operating Revenue	13,726,743	-	-	-	-	11,943,966	Upgrade
Other Revenue	-	13,704,727	13,374,569	13,136,194	12,156,447	-	Upgrade
Revenue	13,726,743	13,704,727	13,374,569	13,136,194	12,156,447	11,943,966	Upgrade
Revenue Growth (YoY)	1.65%	2.47%	1.81%	8.06%	1.78%	0.37%	Upgrade
Cost of Revenue	9,949,932	12,055,156	11,451,659	11,307,208	10,387,854	8,336,712	Upgrade
Gross Profit	3,776,811	1,649,571	1,922,910	1,828,986	1,768,593	3,607,254	Upgrade
Other Operating Expenses	276,774	-	-	-	-	246,142	Upgrade
Operating Expenses	2,017,132	-	-	-	-	1,753,295	Upgrade
Operating Income	1,759,679	1,649,571	1,922,910	1,828,986	1,768,593	1,853,959	Upgrade
Interest Expense	-176,380	-149,015	-109,162	-69,857	-49,849	-42,190	Upgrade
Interest & Investment Income	56,182	43,734	41,630	31,651	29,196	20,957	Upgrade
Earnings From Equity Investments	28,324	25,488	24,206	14,012	19,711	229	Upgrade
Currency Exchange Gain (Loss)	-	-3,812	5,867	3,116	8,086	3,012	Upgrade
Other Non Operating Income (Expenses)	-	-2,580	-1,565	-3,450	-20	-1,109	Upgrade
EBT Excluding Unusual Items	1,667,805	1,563,386	1,883,886	1,804,458	1,775,717	1,834,858	Upgrade
Impairment of Goodwill	-	-	-	-	-	-2,702	Upgrade
Gain (Loss) on Sale of Investments	-	1,310	96,571	13,221	19,808	285	Upgrade
Gain (Loss) on Sale of Assets	-118,991	-	-	-	-	-156,869	Upgrade
Asset Writedown	-21,741	-	-	-	-	-22,997	Upgrade
Pretax Income	1,527,073	1,564,696	1,980,457	1,817,679	1,795,525	1,652,575	Upgrade
Income Tax Expense	460,723	482,261	635,338	524,923	539,531	524,719	Upgrade
Earnings From Continuing Operations	1,066,350	1,082,435	1,345,119	1,292,756	1,255,994	1,127,856	Upgrade
Minority Interest in Earnings	-80,756	-82,419	-65,598	-79,640	-74,911	-211,675	Upgrade
Net Income	985,594	1,000,016	1,279,521	1,213,116	1,181,083	916,181	Upgrade
Net Income to Common	985,594	1,000,016	1,279,521	1,213,116	1,181,083	916,181	Upgrade
Net Income Growth	-16.32%	-21.84%	5.47%	2.71%	28.91%	7.12%	Upgrade
Shares Outstanding (Basic)	83,275	83,611	84,799	87,152	89,670	92,300	Upgrade
Shares Outstanding (Diluted)	83,275	83,611	84,799	87,152	89,670	92,300	Upgrade
Shares Change (YoY)	-1.46%	-1.40%	-2.70%	-2.81%	-2.85%	-0.20%	Upgrade
EPS (Basic)	11.84	11.96	15.09	13.92	13.17	9.93	Upgrade
EPS (Diluted)	11.84	11.96	15.09	13.92	13.17	9.93	Upgrade
EPS Growth	-15.08%	-20.73%	8.40%	5.68%	32.70%	7.33%	Upgrade
Free Cash Flow	538,195	231,739	290,155	409,134	1,252,212	1,213,900	Upgrade
Free Cash Flow Per Share	6.46	2.77	3.42	4.69	13.96	13.15	Upgrade
Dividend Per Share	5.200	5.200	5.100	4.800	4.600	4.200	Upgrade
Dividend Growth	1.96%	1.96%	6.25%	4.35%	9.52%	10.53%	Upgrade
Gross Margin	27.51%	12.04%	14.38%	13.92%	14.55%	30.20%	Upgrade
Operating Margin	12.82%	12.04%	14.38%	13.92%	14.55%	15.52%	Upgrade
Profit Margin	7.18%	7.30%	9.57%	9.23%	9.72%	7.67%	Upgrade
Free Cash Flow Margin	3.92%	1.69%	2.17%	3.12%	10.30%	10.16%	Upgrade
EBITDA	3,500,037	3,371,606	3,551,496	3,411,611	3,329,776	2,798,427	Upgrade
EBITDA Margin	25.50%	24.60%	26.55%	25.97%	27.39%	23.43%	Upgrade
D&A For EBITDA	1,740,358	1,722,035	1,628,586	1,582,625	1,561,183	944,468	Upgrade
EBIT	1,759,679	1,649,571	1,922,910	1,828,986	1,768,593	1,853,959	Upgrade
EBIT Margin	12.82%	12.04%	14.38%	13.92%	14.55%	15.52%	Upgrade
Effective Tax Rate	30.17%	30.82%	32.08%	28.88%	30.05%	31.75%	Upgrade

Updated Feb 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.